GLAXOSMITHKLINE PHARMACEUTICALS LTD. - Change in Directorate

GlaxoSmithKline Pharmaceuticals Ltd has informed BSE as under:<br/><br/>1. The Board of Directors at its Meeting held on November 06, 2014 has appointed Mr. Andrew Aristidou as the Chief Financial Officer and Executive Director of the Company from December 01, 2014.<br/><br/>2. Mr. Mehernosh Kapadia, current Chief Financial Officer and Senior Executive Director will retire from service on November 30, 2014 and will cease to be a Director of the Company from December 01, 2014.<br/><br/>The Board of Directors of the Company have placed on record its warm appreciation of the valuable services rendered by Mr. Mehernosh Kapadia as Director of the Company for over 18 years.